Trevena, Inc. (TRVN): PT Raised News

TRVN – H.C. Wainwright & Co. raises PT to $7. Stock price at the time of this analyst call was $1.88.

Update: As of Mar. 23, 2018, this bullish analyst call has returned -8.51%.

Key Facts Surrounding This News Item

  • TRVN had a POWR Rating of D (Sell) coming into today.
  • TRVN was 3.81% above its 10-Day Moving Average coming into today.
  • TRVN was 8.56% above its 20-Day Moving Average coming into today.
  • TRVN was 8.61% above its 50-Day Moving Average coming into today.
  • TRVN was 11.99% above its 100-Day Moving Average coming into today.
  • TRVN was -10.42% below its 200-Day Moving Average coming into today.
  • TRVN had returned +17.50% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Trevena, Inc. (TRVN)

Trevena Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and intent to commercialize therapeutics for G protein coupled receptors. The company was founded in 2007 and is based in King of Prussia, Pennsylvania. View our full TRVN ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

TRVN at a Glance

TRVN Current POWR Rating™
Overall POWR Rating™
TRVN Current Price $1.72 2.82%
More TRVN Ratings, Data, and News

TRVN Price Reaction

The day of this event (Mar. 8, 2018)
TRVN Closing Price$2.06 9.57%
TRVN Volume1,454,700
97.73% from avg
Leading up to this event
TRVN 1-mo return24.50%
After this event
TRVN 1-day return5.05%
TRVN 3-day return2.08%
TRVN 5-day return0.00%

TRVN Price Chart

More Trevena, Inc. (TRVN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TRVN News
Page generated in 0.9958 seconds.